Scottish Medicines Consortium

This page shows the latest Scottish Medicines Consortium news and features for those working in and with pharma, biotech and healthcare.

Daily Brief: DeepMind and NHS success in AI eyecare, Bayer invests in COPD, Alecensa OK in Scotland

Roche’s Alecensa approved by Scottish Medicines Consortium. Patients in Scotland with untreated, advanced non-small-cell lung cancer (NSCLC) with ALK-positive tumours have a new treatment option available via ... The positive decision from the Scottish

Latest news

Daily Brief: Resignation throws Brexit into disarray, Celgene exec joins Orchard board, Scotland rules on kidney cancer drug

EUSA’s Fotivda approved for NHS use in Scotland. Specialist pharma company EUSA Pharma has welcomed the Scottish Medicines Consortium approval of its renal cell carcinoma treatment Fotivda (tivozanib).
UK, Germany back routine use of J&J’s Tremfya

The National Institute for Health and Care Excellence (NICE) for England and Wales, the Scottish Medicines Consortium (SMC) and Germany’s Federal Joint Committee (G-BA) are the first health technology
Merck and Pfizer set to win NICE backing for Bavencio

The pharma giants are expecting final guidance from NICE within the next coming weeks, and a decision by the Scottish Medicines Consortium (SMC) is also expected.
NICE reverses its rejection of Eisai’s Lenvima

This particular subset of patients in Scotland and Wales can already access Eisai’s medicine due to approvals from the Scottish Medicines Consortium (SMC) and the All Wales Medicines Strategy. ... The positive recommendation comes three years after the
NICE backs Roche’s Gazyvaro after initial rejection

The Scottish Medicines Consortium (SMC) turned down Gazyvaro as a first-line option with chemotherapy last month.

More from news
Approximately 4 fully matching, plus 88 partially matching documents found.

Latest Intelligence

The reality of real-world evidence

Zaltrap re-submission to the Scottish Medicines Consortium (SMC) included RWE (pooled data from two open-label, single-arm studies) to demonstrate prolonged safety and QoL benefit.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Account Director or Senior Account Director: Salary TBC

Integrated Brand/ Digital Senior Account Director, London: Excellent package

Associate Scientific Director: Salary TBC

Senior Account Manager – Healthcare Advertising: Salary TBC

Medical Writers Required - Hertfordshire: Competitive

Science Writer, Healthcare Advertising Agency: £40, 000 - 45, 000 DOE benefits,

Account Director, Healthcare Communications Agency: £54, 000- £60, 000

Senior Writer, Healthcare Advertising, London: Excellent package

Senior Strategist/ Planner, Healthcare Marketing, London: Excellent package

Digital Account Director – Health/ Pharma – Global Agency: Salary TBC

Account Manager, Healthcare Advertising: £30 - 38, 000 (or -)

Account Manager: Negotiable

Deputy Managing Director – Healthcare PR – Global Agency: Negotiable

Head of Market Access - International - Based Cambridge: Excellent Basic, Bonus and Flex Benefits

Principal Medical Writer / Editorial Director – Medical Communic...: £60, 000 - £80, 000

Senior Training Manager - Surrey: Competitive Salary &Bonus

Editorial Director – Medical Education: Neg

Sudler London - Account Director: Competitive

Senior Medical Writer: Salary is DOE

Senior Account Manager / Account Director - Medical Education – ...: Salary TBC

Senior Medical Writer, MedComms Agency: £40 - 55, 000 according to skills and experience benefits

Account Director, Medical Communications & Events: £50 - 65, 000 according to skills and experience benefits

Systematic Review Lead- London: Negotiable

Scientific Director – Medical Communications - New York or Remot...: $100000 - $150000

Healthcare PR Senior Account Manager: Salary TBC

Subscribe to our email news alerts

PMHub

Add my company

Havas Life Medicom

We’re a specialist-led, unified communications agency delivering connected healthcare communications, informed through fresh insights, smart thinking and inspired ideas. Our...

Latest intelligence

PM Society Digital Awards – the power of together: Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduce anyone in four simple steps: You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government: GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....